Michael Dagley is a Melbourne-based Associate Principal in the Management Consulting division of IQVIA, where he provides strategic advisory services to pharmaceutical, biotechnology and government clients. He has led projects for Australian state governments to deliver strategies to grow clinical trials and increase the uptake of teletrials. Michael holds an MBA, with distinction from the University of Oxford and a PhD in biochemistry from the University of Melbourne.